Answers are grounded in this paper and cite their sources.
Mantle cell lymphoma is clinically and biologically heterogeneous disease, ranging from the indolent non-nodal leukemic variant to the highly malignant blastoid variant. Despite many recent therapeutic advances, mantle cell lymphoma (MCL) remains a largely incurable disease. The median age at diagnosis of MCL is 60–65 years. MCL usually presents with advanced extra nodal, bone marrow, peripheral blood, spleen, and gastrointestinal involvement. First-line treatment consists of chemoimmunotherapy, which may result in prolonged remission, but relapse should be expected. Sustained long-term remissions are achievable following autologous stem cell transplantation. In this case report, we present a case of MCL in 60-year-old men diagnosed initially presented with an abdominal tumor. The patient underwent autologous stem cell transplantation after achieving first remission.
No takes yet. Share an insight, caveat, or question.
Svetlana Krstevska Balkanov (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: